Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2026 Volume 31 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2026 Volume 31 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence

  • Authors:
    • Maiko Tabuchi
    • Yasuhiko Nakao
    • Hitomi Minami
    • Hiroko Inomata
    • Junya Shiota
    • Taro Akashi
    • Keiichi Hashiguchi
    • Moto Kitayama
    • Kayoko Matsushima
    • Naoyuki Yamaguchi
    • Yuko Akazawa
    • Hisamitsu Miyaaki
  • View Affiliations / Copyright

    Affiliations: Department of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki 852‑8523, Japan, Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki 852‑8501, Japan
    Copyright: © Tabuchi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 76
    |
    Published online on: January 21, 2026
       https://doi.org/10.3892/etm.2026.13071
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Esophageal high‑resolution manometry (HRM) is an important tool for diagnosing and assessing esophageal achalasia. Artificial intelligence (AI)‑assisted HRM image processing has the potential to aid in the diagnosis of esophageal achalasia. However, addressing the challenges associated with the ‘black‑box’ problem is important. In the present study, an automated system that utilizes AI with class‑activation maps to highlight diagnostic areas in HRM images was developed. A total of 211 HRM images, which led to the diagnosis of controls and patients with achalasia, were used to train the system using Resnet34, a convolutional neural network model. The diagnoses included normal, type I achalasia, type II achalasia, type III achalasia and hypercontractile esophagus based on the Chicago classification v3.0 for esophageal motility disorders. A gradient class activation map (Grad‑CAM) technique was used. The discrimination model for the control and achalasia groups yielded a 100% correct response rate for evaluating the validation images (n=30). Grad‑CAM analysis revealed that the model focused on the area around the lower esophageal sphincter pressure in type 1 achalasia for differentiation, closely aligning with expert perspectives. An AI‑based HRM imaging assistance system may not only support physicians in distinguishing esophageal motility disorders with improved diagnostic accuracy but also serve as a novel tool that provides deeper clinical insights and highlights key interpretative features in HRM evaluations. Further large‑scale validation is required to confirm its clinical utility.

Introduction

Achalasia is a rare motility disorder of the esophagus characterized by dysphagia, chest pain, and weight loss (1,2). It has an annual incidence of one in 100,000 individuals and a prevalence of 10 in 100,000 individuals, and occurs equally in male and female patients (3). Although the exact cause remains largely unknown, a combination of genetic and environmental factors, such as viral infection-mediated immune reactions, may lead to ganglionitis and the loss of esophageal neurons (1,4,5). Achalasia is defined by a combination of symptoms, endoscopic findings, esophagography, and esophageal high-resolution manometry (HRM) (2,6).

Although the underlying causes and variations in esophageal motility disorders remain largely unknown, HRM has emerged as an essential tool for defining and detecting these disorders (2,6). The Chicago classification using HRM is helpful for the diagnosis and pretreatment evaluation of esophageal achalasia (7). The integrated relaxation pressure (IRP) indicates the elevation of the lower esophageal sphincter (LES) pressure for several seconds after swallowing (8). In the Chicago classification, this value serves as the starting point for developing the algorithm, indicating an abnormal motility disorder (7). However, relying solely on the IRP in the algorithm is often inconsistent with the clinical diagnosis (9); therefore, a comprehensive assessment by a physician, incorporating other modalities, is usually necessary. The IRP value, essential for diagnosis, is dynamic and influenced by factors such as diaphragmatic activity, LES function, intrabolus pressure, and catheter positioning (10,11). An accurate interpretation requires a comprehensive assessment that extends beyond the numerical values (11). Interpreting HRM poses significant challenges and requires specialized expertise for an accurate diagnosis. This exclusive reliance on specialists for this diagnostic procedure has led to delays in identifying esophageal motility disorders, such as achalasia.

Artificial intelligence (AI) can alleviate issues associated with the clinical interpretation of HRM. Due to the rarity of this disease, few studies have assessed AI in patients with achalasia. Kou et al (12) first demonstrated a deep learning-based model for diagnosing achalasia using HRM images, employing a variational autoencoder (VAE). Surdea-Blaga et al (13) demonstrated the classification of swallowing disorders using the DenseNet201 convolutional neural network (CNN) architecture combined with the automated Chicago classification, yielding 86% accuracy without human intervention. Although AI-based tools are emerging in the medical field, a black-box problem arises: they do not reveal how or why they were concluded. In AI-based achalasia, whether AI focuses on the same area as clinicians remains unclear.

In this study, we validated an automated diagnostic system using AI to assess HRM. In addition, we utilized a gradient class activation map (Grad-CAM) to evaluate the features of HRM, where the AI focused on distinguishing achalasia from other esophageal motor disorders.

Materials and methods

Data collection and ethical approval

The research implementation system was conducted at a single center. This retrospective study was approved by the Nagasaki University Hospital Research Ethics Committee. This retrospective study was approved by the ethics review board and the requirement for informed consent was waived.

Data pre-processing

A total of 211 HRM images were de-identified to protect patient confidentiality and were collected between December 2018 and August 2022 at the Nagasaki University Hospital. Typical HRM images obtained from patients with achalasia who underwent POEM were used as achalasia images, whereas HRM images from asymptomatic individuals were used as normal controls. Images that were unclear or diagnostically ambiguous were excluded from the analyses. Before submitting the images for model training, each image was cropped to remove the patient identification, machine settings, annotations, and scale bars. High-resolution esophageal manometry was performed using the Starlet system (Star Medical, Tokyo, Japan).

We selected tracings from ten test swallows for analysis (n=22 patients; 211 images): achalasia type I, 67 images; achalasia type II, 30 images; achalasia type III, 9 images; hypercontractile esophagus, 20 images; and normal esophageal motility, 97 images. We used the raw data, which contained only the markers mentioned above (vertical white lines) preceding each wet swallow. The manometry software enabled the storage of 60 s long images of the recordings, which represented the raw images. The region of interest (wet swallowing) was marked with a white vertical line during the procedure. For each patient, we created a folder with ten images, with each image representing a test swallow.

Each set is assigned a diagnostic category. We used five diagnostic categories as follows: normal, type I achalasia, type II achalasia, type III achalasia, and hypercontractile esophagus, based on the Chicago v3.0 classification for esophageal motility disorders (7).

Developing a deep learning algorithm

Achalasia was predicted by using the CNN. The ResNet-34 network was used as the backbone of the encoder network to encode the downsampling layer of the image. The model was trained using Python 3.8 (Python Software Foundation, Beaverton, OR, USA), Pytorch 1.8.1 (The Linux Foundation), and an Nvidia RTX A6000 graphics card. The achalasia prediction training process utilized a mean-squared error loss function and an Adam optimizer with a batch size of 4; the learning rate decreased linearly from 5e-4 to 1e-6.

Grad-CAM method

Grad-CAM was used to reconstruct the image and localize intensive areas for feature extraction. This method identifies the image features used by a CNN to perform the decision-making process, thereby enabling an understanding of the predictive features determined by the trained model. We used Grad-CAM to identify key abnormal features in the dataset. Regions with high feature extraction intensities were assumed to be key points in identifying anomalies.

Dimensions reduction analysis

Principal component analysis (PCA) and three-dimensional t-distributed stochastic neighbor embedding (3D-tSNE) were used for feature analysis of the entire image (14). PCA was used to reduce the dimensions. A TensorBoard Embedding Projector, which offers 3D-tSNE views, was used to compute the top ten principal components. These components were projected onto a combination of three components. The most popular nonlinear dimensionality reduction technique is t-SNE (15).

Statistical analysis

Testing accuracy, sensitivity, and specificity, as calculated from the confusion matrix, were used to evaluate the models. The receiver operating characteristic (ROC) curve, which is a graphical plot highly correlated with the confusion matrix, was also used as an evaluation index. Diagnostic accuracy based on the confusion matrix was calculated as follows: (true positives + true negatives)/(true positives + true negatives + false positives + false negatives). All statistical analyses were performed using the R statistical software (version 4.1.1; The R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at P<0.05.

Results

All patients with achalasia included in the study were treatment-naïve and had no prior interventions, such as balloon dilation, Heller myotomy, or peroral endoscopic myotomy (POEM) (Table I). The training process for the achalasia-2CNN is illustrated in Fig. 1. First, we developed an achalasia prediction model using HRM with CNN (Fig. 1). The ResNet-34 model, which has already been proven to be versatile, was used for transfer learning. Two hundred images were divided into training and validation datasets, and a CNN based primarily on the PyTorch framework was used. With training, the accuracy of the training and validation sets increased, and the loss value decreased. The accuracy of the validation set was highest in the fourth epoch of training (Fig. 2, left panel). Fig. 2 (right panel) shows that the confusion matrix of the achalasia-CNN optimal model was 100% accurate for the external test set, with both sensitivity and specificity reaching 100%. The receiver operating characteristic (ROC) curve, area under the curve (AUC), sensitivity, and specificity are shown in Table SI and Fig. S1.

Learning process involving ResNet-34.
Standard high-resolution manometry images and images from patients
with achalasia were provided as inputs and labeled as ‘Control’ and
‘Achalasia’, respectively. The output represents the probability of
the validation image being classified as either ‘Control’ or
‘Achalasia’. Conv, convolutional layer; fc, fully connected
layer.

Figure 1

Learning process involving ResNet-34. Standard high-resolution manometry images and images from patients with achalasia were provided as inputs and labeled as ‘Control’ and ‘Achalasia’, respectively. The output represents the probability of the validation image being classified as either ‘Control’ or ‘Achalasia’. Conv, convolutional layer; fc, fully connected layer.

Training a ResNet-34 model to
distinguish achalasia from normal esophagus. The left panel shows
the learning process, which was repeated four times using
ResNet-34. The right panel shows validation data with 100% accuracy
across the validation dataset. ‘Train loss’ and ‘valid loss’
indicate the loss values computed for the training and validation
datasets, respectively. The time indicates the duration required
for each epoch (mm:ss).

Figure 2

Training a ResNet-34 model to distinguish achalasia from normal esophagus. The left panel shows the learning process, which was repeated four times using ResNet-34. The right panel shows validation data with 100% accuracy across the validation dataset. ‘Train loss’ and ‘valid loss’ indicate the loss values computed for the training and validation datasets, respectively. The time indicates the duration required for each epoch (mm:ss).

Table I

Patient characteristics.

Table I

Patient characteristics.

CharacteristicsAchalasia (n=12)Normal (n=9)
Age, years41 (16-89)72 (50-82)
Sex (male)7(58)6(67)
Eckardt score (normal, ≤3)7 (1-10)0 (0-0)
Prior treatment (yes)0 (0)0 (0)
IRP, mmHg (normal, ≤25 mmHg)23.6 (0.6-55.0)10.4 (3.6-18.5)
Maximum DCI, mmHg·sec·cm (normal range, 450-8,000 mmHg·sec·cm)796.1 (397.0-493,490.0)1,701.1 (238.1-3,713.1)

[i] Data are presented as the median (range) or n (%). IRP, integrated relaxation pressure; DCI, distal contractile integral.

Owing to the nearly 100% correct response rate, and despite the small dataset, PCA was performed on the characteristics of the dataset. The HRM of patients with achalasia was distributed mainly on the left side of Fig. 3, indicating that the features of each HRM image differed between the controls and patients with achalasia. Similarly, a 3D-tSNE analysis, a dimensionality removal method, was performed (Fig. 4), which showed that the achalasia group could be further subdivided into several groups, suggesting the possibility of extracting features using an achalasia-type classification.

PCA. Images from PCA using the
TensorBoard software. Black panels represent achalasia cases,
whereas blue panels represent control cases. The spatial separation
between the two groups reflects differences in the learned feature
representations. The spatial separation between the two groups
reflects the difference in the learned feature representations.
PCA, principal component analysis.

Figure 3

PCA. Images from PCA using the TensorBoard software. Black panels represent achalasia cases, whereas blue panels represent control cases. The spatial separation between the two groups reflects differences in the learned feature representations. The spatial separation between the two groups reflects the difference in the learned feature representations. PCA, principal component analysis.

Analysis with 3D-tSNE. The figure
shows a combination of principal component analysis and 3D-tSNE
analysis. Black panels represent achalasia cases, whereas blue
panels represent control cases. Notably, an additional subdivision
within the achalasia category was observed, suggesting a more
detailed characterization of the data. 3D-tSNE, three-dimensional
t-distributed stochastic neighbor embedding.

Figure 4

Analysis with 3D-tSNE. The figure shows a combination of principal component analysis and 3D-tSNE analysis. Black panels represent achalasia cases, whereas blue panels represent control cases. Notably, an additional subdivision within the achalasia category was observed, suggesting a more detailed characterization of the data. 3D-tSNE, three-dimensional t-distributed stochastic neighbor embedding.

The difference in HRM features between the controls and patients with achalasia, even in the absence of a large number of HRM images, suggests that deep learning may be predominantly predictive of the disease. Thus, predictors of each type of achalasia were developed using the same methods.

Next, we developed an achalasia-type prediction model using HRM with deep learning. The confusion matrix in Fig. 5 shows the predictions for each type. Of the 22 validation datasets, two were incorrectly classified as type 1 for type 2 achalasia; however, the others were correctly classified (Fig. 6). These results demonstrate that deep learning can achieve high accuracy rates in HRM diagnosis, even with small datasets. The comprehensive performance metrics are presented in Table SII and Fig. S2.

Training of a ResNet-34 model for
classification of achalasia subtypes and hypercontractile
esophagus. The resulting outputs comprised the probabilities of
achalasia types and hypercontractile esophageal classifications
based on validation images. Conv, convolutional layer; fc, fully
connected layer.

Figure 5

Training of a ResNet-34 model for classification of achalasia subtypes and hypercontractile esophagus. The resulting outputs comprised the probabilities of achalasia types and hypercontractile esophageal classifications based on validation images. Conv, convolutional layer; fc, fully connected layer.

Training a ResNet-34 model to
distinguish achalasia typing. The left panel shows the learning
process repeated four times. The right panel shows the validation
data, with an accuracy of 90.9% observed across the validation
dataset for the classification of achalasia type and
hypercontractile esophagus. ‘Train loss’ and ‘valid loss’ indicate
the loss values computed for the training and validation datasets,
respectively. The time indicates the duration required for each
epoch (mm:ss).

Figure 6

Training a ResNet-34 model to distinguish achalasia typing. The left panel shows the learning process repeated four times. The right panel shows the validation data, with an accuracy of 90.9% observed across the validation dataset for the classification of achalasia type and hypercontractile esophagus. ‘Train loss’ and ‘valid loss’ indicate the loss values computed for the training and validation datasets, respectively. The time indicates the duration required for each epoch (mm:ss).

The legends visualized using Grad-CAM are shown in Fig. 7. The images were reviewed by two achalasia diagnosticians, primarily based on the diagnosis, with high-signal images in the heatmap of the LES pressure region, which is a crucial area for achalasia diagnosis.

Grad-CAM visualization highlighting
regions contributing to AI-based classification. Grad-CAM
visualizations show hotspots in the right panels, representing
regions that the AI focused on to distinguish achalasia from
control images. These hotspots, highlighted by the AI, signify
areas where the disease images differ from the control images and
the percentage indicates the predicted probability for each class
obtained from the softmax output. Grad-CAM, gradient class
activation map program; AI, artificial intelligence.

Figure 7

Grad-CAM visualization highlighting regions contributing to AI-based classification. Grad-CAM visualizations show hotspots in the right panels, representing regions that the AI focused on to distinguish achalasia from control images. These hotspots, highlighted by the AI, signify areas where the disease images differ from the control images and the percentage indicates the predicted probability for each class obtained from the softmax output. Grad-CAM, gradient class activation map program; AI, artificial intelligence.

When reexamining the areas of focus of Grad-CAM, we found that pan-esophageal pressurization, which is continuous with upper esophageal sphincter contraction, is a feature of type 2 achalasia (Fig. S3). Interestingly, these features are not found in type 1 achalasia, suggesting that they may be imaging features of type 2 achalasia.

Discussion

In recent years, multimodal therapy combining surgical resection with chemotherapy, chemoradiotherapy, and immunotherapy has become widely adopted for malignant esophageal diseases such as esophageal cancer, leading to significant improvements in patient prognosis (16-19). Furthermore, advances in endoscopic diagnosis have enabled earlier detection of esophageal squamous cell carcinoma (ESCC), and endoscopic submucosal dissection (ESD) for early lesions has markedly improved prognosis (20,21).

In contrast, benign esophageal motility disorders, such as achalasia, require precise functional evaluation and have often been overlooked due to the complexity of diagnostic tools and a limited comprehensive understanding of these conditions (22,23). HRM serves as a highly valuable functional imaging examination tool, and its diagnostic accuracy and progression are pivotal for future elucidation and treatment of the underlying causes of esophageal motility disorders (1,9,24). Once achalasia is accurately diagnosed using HRM, patients can experience marked symptom improvement through appropriate therapeutic interventions, such as peroral endoscopic myotomy (POEM) or Heller-Dor surgery (1,25,26).

However, the diagnosis of esophageal motility disorders using HRM can be highly challenging. Even in achalasia, cases with normal IRP values (9 out of 12 patients, within the normal range of ≤25 mmHg) were observed in our cohort, and such patients cannot always be accurately diagnosed, even when the Chicago Classification is applied. Several studies have reported the presence of achalasia with normal IRP values. Proposed mechanisms include impaired esophagogastric junction opening due to fibrotic changes of the LES (27), as well as advanced age or pronounced esophageal tortuosity and dilatation (28). In addition, when using the Starlet catheter, Type I achalasia may present with lower IRP values than expected (29). Therefore, diagnosing esophageal motility disorders based on HRM topography, rather than relying solely on numerical indices such as IRP, is essential. However, describing and quantifying the image features that serve as diagnostic criteria remains challenging. The present results demonstrate that AI-assisted diagnosis can be a valuable approach for identifying achalasia.

Rare esophageal motility disorders, such as distal esophageal spasm (DES) and esophagogastric junction outflow obstruction (EGJOO), have been reported in previous studies (30). Achalasia is characterized by a selective loss of inhibitory myenteric neurons in the distal esophagus and LES, resulting in impaired esophagogastric junction (EGJ) relaxation and loss of normal peristalsis (31). High-resolution manometry shows an elevated IRP with absent peristalsis, with type I-III subtypes distinguished by the presence of panesophageal pressurization or premature spastic contractions. In contrast, EGJ outflow obstruction is defined in the Chicago Classification as an elevated median IRP with preserved- or only weakly impaired-peristalsis, and is considered a heterogeneous manometric pattern that may reflect early or variant achalasia, mechanical obstruction (e.g., hiatal hernia, stricture, malignancy), or post-surgical changes rather than a single primary motility disorder (32). Accordingly, the current Chicago Classification v4.0 requires not only HRM findings but also supportive evidence from endoscopy, timed barium esophagram, or functional lumen imaging probe (FLIP) to distinguish clinically relevant EGJOO from incidental manometric abnormalities (33). Distal esophageal spasm (DES) is thought to result from an imbalance between excitatory and inhibitory innervation confined mainly to the distal esophagus; HRM in DES demonstrates premature contractions (distal latency <4.5 s) in ≥20% of swallows with normal EGJ relaxation, typically in patients with dysphagia or non-cardiac chest pain (34). Thus, while all three conditions share abnormalities in inhibitory neural control of the esophagus, achalasia is defined by impaired EGJ relaxation with absent peristalsis, EGJOO by impaired EGJ relaxation with preserved peristalsis, and DES by premature distal contractions with normal EGJ relaxation. In HRM, premature contractions can also be observed in type III achalasia, and some achalasia cases may present with normal IRP values, making it easily confused with DES. Moreover, EGJOO cannot be accurately diagnosed based solely on HRM findings; additional evaluations, such as endoscopy, timed barium esophagram, or FLIP, are required to confirm true obstruction. Therefore, we considered DES and EGJOO to be inappropriate as the initial targets for AI model development.

In this study, we developed and validated an achalasia prediction and classification model using HRM with deep learning. To the best of our knowledge, this is the first time AI has demonstrated the potential to support medical practice by visualizing AI prediction sites using Grad-CAM and reevaluating them from a physician's perspective. Few reports are available on the use of deep learning for HRM images. For example, models based on VAE and DenseNet201(35) have been shown to achieve high accuracy rates, reaching approximately 93% in classifying esophageal motility disorders (36). In addition, Kou et al (37) reported that a Long Short-Term Memory (LSTM) model achieved a correct classification rate of 88% for the Chicago Classification using HRM images. We employed a relatively generic convolutional neural network, ResNet-34(38), with transfer learning for HRM image classification, achieving a correct classification rate of 95%, consistent with prior deep-learning studies. To investigate the underlying cause, we conducted PCA and 3D-tSNE analyses, which indicated that the discriminative challenge could be advantageous for AI in distinguishing between normal HRM and achalasia cases, given the fundamental differences in the image features. Although the internal validation yielded AUCs of 1.000 and very high sensitivity and specificity, these figures should be regarded as optimistic estimates rather than evidence of perfect clinical performance. The validation sets were small (22 cases for the multiclass task and 30 cases for the binary task), and with such sample sizes, an empirically perfect ROC curve can occur when the model ranks all cases correctly in a single split. In addition, we fine-tuned a pre-trained ResNet-34 model on data from a single source, which increases the risk of overfitting to the local data distribution. Therefore, the present results should be interpreted as showing that the model can separate these particular data well, and not that it will achieve 100% accuracy in broader practice. Future studies should include repeated cross-validation and, more importantly, external validation in a larger and more heterogeneous cohort.

Previous studies have reported that AI prediction of HRM images is helpful for the Chicago classification of achalasia, achieving a high accuracy level of 81-93% (37,39). In this study, our validation dataset yielded a classification accuracy of 95% for the Chicago Classification groups. Furthermore, we not only developed a classification model but also applied Grad-CAM to visualize the regions contributing to the AI's predictions and reviewed all images from the perspective of esophageal specialists. The Grad-CAM results also focused on LES pressure in the HRM image, demonstrating that the LES plays a crucial role in representing pathological function, as mentioned previously (40). These findings are valuable for guiding treatment choices. Grad-CAM images can be instrumental in determining whether to cut or preserve the LES during procedures such as peroral endoscopic myotomy, diffuse esophageal spasm, and hypercontractile esophagus, which are collectively referred to as esophageal motility disorders (30).

In the future, we plan to introduce our developed model in medical practice and investigate its potential not only for the identification of achalasia but also as a tool for medical education, supporting residents and other physicians through AI-assisted diagnostics.

A limitation of HRM is that it is primarily used to evaluate rare diseases, making validation with large datasets and balanced case designs challenging. Therefore, validation on large datasets and with a balanced case design is difficult. Although a discriminator and classification model for achalasia was developed in this study, further development and validation of the model were constrained by the lack of sufficient training data for other rare esophageal diseases. Future directions may include the implementation of abnormality-detection models based on generative adversarial networks, which hold promise for addressing these limitations.

In conclusion, our AI-based HRM assistance system not only enhances diagnostic accuracy but also offers clinicians new insights and interpretative perspectives for HRM evaluation. Further large-scale studies are required to validate its utility.

Supplementary Material

Binary ROC curve for control vs. achalasia (positive=achalasia). The solid line is the ROC curve; the diagonal dotted line indicates the line of no discrimination. AUC, 1.000 (bootstrap 95% CI, 1.000-1.000). The sensitivity, specificity and accuracy at a fixed probability threshold of 0.5 are reported in Table SI. AUC, area under the curve; ROC, receiver operating characteristic.
Multiclass ROC curves (one vs. rest) for type 1, type 2 and type 3 achalasia, and hypercontractile esophagus. Solid lines denote class-specific ROC curves; the dashed line indicates the micro-average ROC. The diagonal dotted line indicates the line of no discrimination. AUCs: Class-wise, 1.000 for all classes; micro-average, 0.999 (95% CI, 0.996-1.000); macro-average, 1.000 (95% CI, 1.000-1.000). The macro-average AUC value is reported; however, a macro-average ROC curve is not displayed because the macro-average AUC represents an average of the class-specific AUCs and does not correspond to a single ROC curve. AUC, area under the curve; ROC, receiver operating characteristic.
Examples of gradient class activation map images. In achalasia type 2, a persistent increase in panesophageal pressure was observed accompanied by lower esophageal sphincter and UES contraction (upper panel; yellow arrow). By contrast, patients with achalasia type 1 exhibit no concurrent increase in esophageal pressure during UES contraction (lower panel; yellow arrow). This observation may serve as an imaging characteristic specific to achalasia type 2. The percentage indicates the predicted probability for each class obtained from the softmax output. UES, upper esophageal sphincter.
Comprehensive performance metrics for binary tasks (control vs. achalasia; positive = achalasia).
Comprehensive performance metrics for multiclass tasks (type 1, type 2 and type 3 achalasia, and hypercontractile esophagus).

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study are not publicly available because they contain information that could compromise the privacy of research participants, but may be requested from the corresponding author.

Authors' contributions

MT and YN conducted the experiments and wrote the manuscript. HMin, NY, YA and HMiy made substantial contributions to the conception and design of the study. MT, HI, JS, TA, KH, MK, KM and HMin contributed to acquisition and analysis of data. NY, YA and HMiy critically revised the manuscript for important intellectual content. HMin, JS and YN confirm the authenticity of all the raw data. All authors have read and approved the final version of the manuscript.

Ethics approval and consent to participate

The study protocol was reviewed and approved by the Nagasaki University Hospital Research Ethics Committee (approval no. 23041703-2; Nagasaki, Japan), and the need for informed consent was waived. The hospital website ensures that patients have the right to refuse to share information through an opt-out system.

Patient consent for publication

Patient consent for publication was obtained using an opt-out approach, whereby the study information was publicly disclosed, as approved by the Nagasaki University Hospital Research Ethics Committee.

Competing interests

The authors declare that they have no competing interests.

Use of artificial intelligence tools

During the preparation of this work, artificial intelligence tools were used to improve the readability and language of the manuscript or to generate images, and subsequently, the authors revised and edited the content produced by the artificial intelligence tools as necessary, taking full responsibility for the ultimate content of the present manuscript.

References

1 

Boeckxstaens GE, Zaninotto G and Richter JE: Achalasia. Lancet. 383:83–93. 2014.PubMed/NCBI View Article : Google Scholar

2 

Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB and Kavitt RT: ACG clinical guidelines: Diagnosis and management of achalasia. Am J Gastroenterol. 115:1393–1411. 2020.PubMed/NCBI View Article : Google Scholar

3 

Vaezi MF, Pandolfino JE and Vela MF: ACG clinical guideline: Diagnosis and management of achalasia. Am J Gastroenterol. 108:1238–1249, 1250. 2013.PubMed/NCBI View Article : Google Scholar

4 

Naik RD, Vaezi MF, Gershon AA, Higginbotham T, Chen JJ, Flores E, Holzman M, Patel D and Gershon MD: Association of achalasia with active varicella zoster virus infection of the esophagus. Gastroenterology. 161:719–721.e2. 2021.PubMed/NCBI View Article : Google Scholar

5 

Gaber CE, Cotton CC, Eluri S, Lund JL, Farrell TM and Dellon ES: Autoimmune and viral risk factors are associated with achalasia: A case-control study. Neurogastroenterol Motil. 34(e14312)2022.PubMed/NCBI View Article : Google Scholar

6 

Yamasaki T, Tomita T, Mori S, Takimoto M, Tamura A, Hara K, Kondo T, Kono T, Tozawa K, Ohda Y, et al: Esophagography in patients with esophageal achalasia diagnosed with high-resolution esophageal manometry. J Neurogastroenterol Motil. 24:403–409. 2018.PubMed/NCBI View Article : Google Scholar

7 

Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ and Pandolfino JE: International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 27:160–174. 2015.PubMed/NCBI View Article : Google Scholar

8 

do Carmo GC, de Assis Mota G, da Silva Castro Perdoná G and de Oliveira RB: Integrated relaxation pressure and its diagnostic ability may vary according to the conditions used for HREM recording. Dysphagia. 39:746–756. 2024.PubMed/NCBI View Article : Google Scholar

9 

Cha B and Jung KW: Diagnosis of dysphagia: High resolution manometry & EndoFLIP. Korean J Gastroenterol. 77:64–70. 2021.PubMed/NCBI View Article : Google Scholar : (In Korean).

10 

Czako Z, Surdea-Blaga T, Sebestyen G, Hangan A, Dumitrascu DL, David L, Chiarioni G, Savarino E and Popa SL: Integrated relaxation pressure classification and probe positioning failure detection in high-resolution esophageal manometry using machine learning. Sensors (Basel). 22(253)2021.PubMed/NCBI View Article : Google Scholar

11 

Gong EJ: Integrated relaxation pressure during swallowing: An Ever-changing metric. J Neurogastroenterol Motil. 27:151–152. 2021.PubMed/NCBI View Article : Google Scholar

12 

Kou W, Carlson DA, Baumann AJ, Donnan E, Luo Y, Pandolfino JE and Etemadi M: A deep-learning-based unsupervised model on esophageal manometry using variational autoencoder. Artif Intell Med. 112(102006)2021.PubMed/NCBI View Article : Google Scholar

13 

Surdea-Blaga T, Sebestyen G, Czako Z, Hangan A, Dumitrascu DL, Ismaiel A, David L, Zsigmond I, Chiarioni G, Savarino E, et al: Automated Chicago classification for esophageal motility disorder diagnosis using machine learning. Sensors (Basel). 22(5227)2022.PubMed/NCBI View Article : Google Scholar

14 

Luus F, Khan N and Akhalwaya I: Active learning with tensorboard projector. arXiv.org, 2019.

15 

Van der Maaten L and Hinton G: Visualizing data using t-SNE. J Mach Learn Res. 9:2579–2605. 2008.

16 

Kanamori K, Koyanagi K, Ozawa S, Yamamoto M, Ninomiya Y, Yatabe K, Higuchi T and Tajima K: Multimodal therapy for esophageal squamous cell carcinoma according to TNM staging in Japan-a narrative review of clinical trials conducted by Japan clinical oncology group. Ann Esophagus. 6(32)2023.

17 

Koyanagi K, Kanamori K, Ninomiya Y, Yatabe K, Higuchi T, Yamamoto M, Tajima K and Ozawa S: Progress in multimodal treatment for advanced esophageal squamous cell carcinoma: Results of multi-institutional trials conducted in Japan. Cancers (Basel). 13(51)2020.PubMed/NCBI View Article : Google Scholar

18 

Higuchi T, Shoji Y, Koyanagi K, Tajima K, Kanamori K, Ogimi M, Yatabe K, Ninomiya Y, Yamamoto M, Kazuno A, et al: Multimodal treatment strategies to improve the prognosis of locally advanced thoracic esophageal squamous cell carcinoma: A narrative review. Cancers (Basel). 15(10)2022.PubMed/NCBI View Article : Google Scholar

19 

Bolger JC, Donohoe CL, Lowery M and Reynolds JV: Advances in the curative management of oesophageal cancer. Br J Cancer. 126:706–717. 2022.PubMed/NCBI View Article : Google Scholar

20 

Yang H, Wang F, Hallemeier CL, Lerut T and Fu J: Oesophageal cancer. Lancet. 404:1991–2005. 2024.PubMed/NCBI View Article : Google Scholar

21 

Nishizawa T and Suzuki H: Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Cancers (Basel). 12(2849)2020.PubMed/NCBI View Article : Google Scholar

22 

Averbukh LD and Tadros M: The role of automatically generated Chicago classification in delayed achalasia diagnosis. ACG Case Rep J. 7(e00345)2020.PubMed/NCBI View Article : Google Scholar

23 

Müller M, Förschler S, Wehrmann T, Marini F, Gockel I and Eckardt AJ: Atypical presentations and pitfalls of achalasia. Dis Esophagus. 36(doad029)2023.PubMed/NCBI View Article : Google Scholar

24 

Richter JE: High-resolution manometry in diagnosis and treatment of achalasia: Help or hype. Curr Gastroenterol Rep. 16(420)2014.PubMed/NCBI View Article : Google Scholar

25 

Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H and Kudo S: Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 42:265–271. 2010.PubMed/NCBI View Article : Google Scholar

26 

Schlottmann F and Patti MG: Esophageal achalasia: Current diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 12:711–721. 2018.PubMed/NCBI View Article : Google Scholar

27 

Sato H, Takahashi K, Mizuno KI, Hashimoto S, Yokoyama J and Terai S: A clinical study of peroral endoscopic myotomy reveals that impaired lower esophageal sphincter relaxation in achalasia is not only defined by high-resolution manometry. PLoS One. 13(e0195423)2018.PubMed/NCBI View Article : Google Scholar

28 

Kim E, Yoo IK, Yon DK, Cho JY and Hong SP: Characteristics of a subset of achalasia with normal integrated relaxation pressure. J Neurogastroenterol Motil. 26:274–280. 2020.PubMed/NCBI View Article : Google Scholar

29 

Kawami N, Hoshino S, Hoshikawa Y, Takenouchi N, Hanada Y, Tanabe T, Goto O, Kaise M and Iwakiri K: Validity of the cutoff value for integrated relaxation pressure used in the Starlet high-resolution manometry system. J Nippon Med Sch. 86:322–326. 2020.PubMed/NCBI View Article : Google Scholar

30 

Morley TJ, Mikulski MF, Rade M, Chalhoub J, Desilets DJ and Romanelli JR: Per-oral endoscopic myotomy for the treatment of non-achalasia esophageal dysmotility disorders: Experience from a single high-volume center. Surg Endosc. 37:1013–1020. 2023.PubMed/NCBI View Article : Google Scholar

31 

Rogers AB, Rogers BD and Gyawali CP: Pathophysiology of achalasia. Ann Esophagus. 3(27)2020.

32 

Rohof WOA and Bredenoord AJ: Chicago classification of esophageal motility disorders: Lessons learned. Curr Gastroenterol Rep. 19(37)2017.PubMed/NCBI View Article : Google Scholar

33 

Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, Babaei A, Mittal RK, Rommel N, Savarino E, et al: Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 33(e14058)2021.PubMed/NCBI View Article : Google Scholar

34 

Fox MR, Sweis R, Yadlapati R, Pandolfino J, Hani A, Defilippi C, Jan T and Rommel N: Chicago classification version 4.0© technical review: Update on standard high-resolution manometry protocol for the assessment of esophageal motility. Neurogastroenterol Motil. 33(e14120)2021.PubMed/NCBI View Article : Google Scholar

35 

Huang G, Liu Z, Pleiss G, van der Maaten L and Weinberger KQ: Convolutional networks with dense connectivity. IEEE Trans Pattern Anal Mach Intell. 44:8704–8716. 2022.PubMed/NCBI View Article : Google Scholar

36 

Popa SL, Surdea-Blaga T, Dumitrascu DL, Chiarioni G, Savarino E, David L, Ismaiel A, Leucuta DC, Zsigmond I, Sebestyen G, et al: Automatic diagnosis of high-resolution esophageal manometry using artificial intelligence. J Gastrointestin Liver Dis. 31:383–389. 2022.PubMed/NCBI View Article : Google Scholar

37 

Kou W, Galal GO, Klug MW, Mukhin V, Carlson DA, Etemadi M, Kahrilas PJ and Pandolfino JE: Deep learning-based artificial intelligence model for identifying swallow types in esophageal high-resolution manometry. Neurogastroenterol Motil. 34(e14290)2022.PubMed/NCBI View Article : Google Scholar

38 

He K, Zhang X, Ren S and Sun J: Deep residual learning for image recognition. arXiv. [csCV]:770–778. 2015.

39 

Kou W, Carlson DA, Baumann AJ, Donnan EN, Schauer JM, Etemadi M and Pandolfino JE: A multi-stage machine learning model for diagnosis of esophageal manometry. Artif Intell Med. 124(102233)2022.PubMed/NCBI View Article : Google Scholar

40 

Cohen S, Lipshutz W and Hughes W: Role of gastrin supersensitivity in the pathogenesis of lower esophageal sphincter hypertension in achalasia. J Clin Invest. 50:1241–1247. 1971.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tabuchi M, Nakao Y, Minami H, Inomata H, Shiota J, Akashi T, Hashiguchi K, Kitayama M, Matsushima K, Yamaguchi N, Yamaguchi N, et al: <p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>. Exp Ther Med 31: 76, 2026.
APA
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T. ... Miyaaki, H. (2026). <p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>. Experimental and Therapeutic Medicine, 31, 76. https://doi.org/10.3892/etm.2026.13071
MLA
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T., Hashiguchi, K., Kitayama, M., Matsushima, K., Yamaguchi, N., Akazawa, Y., Miyaaki, H."<p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>". Experimental and Therapeutic Medicine 31.3 (2026): 76.
Chicago
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T., Hashiguchi, K., Kitayama, M., Matsushima, K., Yamaguchi, N., Akazawa, Y., Miyaaki, H."<p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>". Experimental and Therapeutic Medicine 31, no. 3 (2026): 76. https://doi.org/10.3892/etm.2026.13071
Copy and paste a formatted citation
x
Spandidos Publications style
Tabuchi M, Nakao Y, Minami H, Inomata H, Shiota J, Akashi T, Hashiguchi K, Kitayama M, Matsushima K, Yamaguchi N, Yamaguchi N, et al: <p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>. Exp Ther Med 31: 76, 2026.
APA
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T. ... Miyaaki, H. (2026). <p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>. Experimental and Therapeutic Medicine, 31, 76. https://doi.org/10.3892/etm.2026.13071
MLA
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T., Hashiguchi, K., Kitayama, M., Matsushima, K., Yamaguchi, N., Akazawa, Y., Miyaaki, H."<p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>". Experimental and Therapeutic Medicine 31.3 (2026): 76.
Chicago
Tabuchi, M., Nakao, Y., Minami, H., Inomata, H., Shiota, J., Akashi, T., Hashiguchi, K., Kitayama, M., Matsushima, K., Yamaguchi, N., Akazawa, Y., Miyaaki, H."<p>Development of a diagnostic model for esophageal achalasia assessed by esophageal high‑resolution manometry using artificial intelligence</p>". Experimental and Therapeutic Medicine 31, no. 3 (2026): 76. https://doi.org/10.3892/etm.2026.13071
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team